Atrial Fibrillation, Persistent Clinical Trials
2 recruiting trials for Atrial Fibrillation, Persistent. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Atrial Fibrillation, Persistent clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by St. George's Hospital, London (1), Barts & The London NHS Trust (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is AtriCure EPi-Sense-AF Guided Coagulation System +/- Atriclip (device, 1 trial), followed by Endocardial Catheter Ablation, Epicardial AF ablation using AtriCure EPi-Sense-AF Guided Coagulation System with Left Atrial Appendage Exclusion using the AtriCure LARIAT Suture Delivery Device..
Track Atrial Fibrillation, Persistent trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Hybrid Ablation of Atrial Fibrillation in Heart Failure
A randomised controlled trial to assess the efficacy of staged hybrid ablation when compared with standard catheter ablation in patients with non-paroxysmal atrial fibrillation...
Convergent Ablation Plus Left Atrial Appendage Isolation for the Treatment of Persistent Atrial Fibrillation
A randomised controlled clinical trial to assess efficacy of convergent ablation with the LARIAT procedure, as compared to standard endocardial catheter ablation in patients with...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Atrial Fibrillation, Persistent, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Atrial Fibrillation, Persistent, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Atrial Fibrillation, Persistent, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.